Temat: "prognosis" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis.
Autorzy :: Peng F; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Qin Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Mu S; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Li J; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Ai L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. .
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. .; Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Pokaż więcej
Źródło :: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3123-3135. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Prognosis*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hodgkin Disease/*drug therapy
T-Lymphocytes, Regulatory/*immunology
Hodgkin Disease/immunology ; Hodgkin Disease/pathology ; Humans ; Lymphocytes/immunology ; Lymphocytes/pathology ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/immunology ; Lymphoma, Large B-Cell, Diffuse/pathology ; Progression-Free Survival ; T-Lymphocytes, Regulatory/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Predictors of outcome in childhood Plasmodium falciparum malaria.
Autorzy :: Patel H; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Dunican C; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Cunnington AJ; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.; Pokaż więcej
Źródło :: Virulence [Virulence] 2020 Dec; Vol. 11 (1), pp. 199-221.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Prognosis*
Malaria, Falciparum/*complications
Malaria, Falciparum/*physiopathology
Acidosis/complications ; Anemia/complications ; Biomarkers ; Child ; Coinfection/complications ; Hemorrhage/complications ; Humans ; Jaundice/complications ; Malaria, Cerebral/complications ; Malaria, Cerebral/mortality ; Malaria, Falciparum/mortality ; Nervous System Diseases/complications ; Plasmodium falciparum/physiology ; Renal Insufficiency/complications ; Respiratory Distress Syndrome/complications ; Shock/complications ; Thrombocytopenia/complications
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy.
Autorzy :: Ko KH; Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Huang HK; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chen YI; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chang H; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tsai WC; Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Huang TW; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. .; Pokaż więcej
Źródło :: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3323-3332. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Lung Neoplasms/*surgery
Neoplasms, Second Primary/*surgery
Adult ; Aged ; Disease-Free Survival ; Female ; Humans ; Lung Neoplasms/epidemiology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms, Second Primary/epidemiology ; Neoplasms, Second Primary/pathology ; Risk Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma.
Autorzy :: Deng J; Nanjing Medical University, Nanjing.; Department of Interventional Radiology.
Chen W; Department of Interventional Radiology.
Wu X; Department of Oncology, The Affiliated Wuxi No. 5 People's Hospital of Jiangnan University, Wuxi.
Zhou Y; Department of Interventional Radiology.
Li J; Department of Infectious diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Jan 08; Vol. 100 (1), pp. e24060.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*standards
Adult ; Aged ; Carcinoma, Hepatocellular/physiopathology ; Chemoembolization, Therapeutic/methods ; Chemoembolization, Therapeutic/statistics & numerical data ; Disease-Free Survival ; Female ; Humans ; Liver Neoplasms/physiopathology ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Survival Analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: The prognosis of early-stage breast cancer in extremely young female patients.
Autorzy :: Chung WP; Institute of Clinical Medicine.; Department of Oncology.; Center of Applied Nanomedicine.
Lee KT; Department of Surgery.
Chen YP; Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hsu YT; Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Loh ZJ; Department of Surgery.
Huang CC; Department of Surgery.
Hsu HP; Department of Surgery.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Jan 08; Vol. 100 (1), pp. e24076.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Time Factors*
Breast Neoplasms/*complications
Adult ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/mortality ; Case-Control Studies ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Retrospective Studies ; Taiwan/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.
Autorzy :: Zhang XY; From Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University.
Zhou LL; From Cancer Center.
Jiao Y; From Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University.
Li YQ; From Department of Pathophysiology, College of Basic Medical Sciences, Jilin University.
Guan YN; From Department of Cardiology.
Zhao YC; From Department of Radiation Oncology, The Second Hospital of Jilin University, Changchun, Jilin, P.R. China.
Zheng LW; From Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Jan 08; Vol. 100 (1), pp. e24134.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Adenylate Kinase/*analysis
Ovarian Neoplasms/*complications
Adenylate Kinase/blood ; Adenylate Kinase/genetics ; Aged ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Down-Regulation ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Ovarian Neoplasms/blood ; Ovarian Neoplasms/classification
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Decreased albumin is associated with elevated N-terminal pro-brain natriuretic peptide and poor long-term prognosis in patients with chronic heart failure.
Autorzy :: Yi S; Intensive Care Unit, Central Hospital of Hengyang, Hengyang, Hunan.; Guangxi Medical University.
Chen M; Department of Intensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 18; Vol. 99 (51), pp. e23872.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Survivors*
Heart Failure/*physiopathology
Natriuretic Peptide, Brain/*analysis
Peptide Fragments/*analysis
Serum Albumin, Human/*analysis
Aged ; Cohort Studies ; Female ; Heart Failure/blood ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: The relationship between hepatoma-derived growth factor and prognosis in non-small cell lung cancer: A systematic review and meta-analysis.
Autorzy :: Koh HM; Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon.
Hyun CL; Department of Pathology, Jeju National University School of Medicine.; Department of Pathology, Jeju National University Hospital, Jeju.
Jang BG; Department of Pathology, Jeju National University School of Medicine.; Department of Pathology, Jeju National University Hospital, Jeju.
Lee HJ; Department of Pathology, Soonchunhyang University College of Medicine, Cheonan.; Department of Pathology, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 18; Vol. 99 (51), pp. e23837.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Carcinoma, Non-Small-Cell Lung/*blood
Intercellular Signaling Peptides and Proteins/*analysis
Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Carcinoma, Non-Small-Cell Lung/mortality ; Disease-Free Survival ; Humans ; Intercellular Signaling Peptides and Proteins/blood ; Meta-Analysis as Topic ; Systematic Reviews as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: General Public Preferences for Allocating Scarce Medical Resources During COVID-19.
Autorzy :: Huseynov S; Texas A&M University, College Station, TX, United States.
Palma MA; Texas A&M University, College Station, TX, United States.
Nayga RM Jr; University of Arkansas, Fayetteville, AR, United States.; Pokaż więcej
Źródło :: Frontiers in public health [Front Public Health] 2020 Dec 11; Vol. 8, pp. 587423. Date of Electronic Publication: 2020 Dec 11 (Print Publication: 2020).
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Hospitalization*
Prognosis*
Resource Allocation*
Health Care Rationing/*ethics
Triage/*ethics
Adult ; Female ; Humans ; Male ; Quality-Adjusted Life Years ; United States ; Ventilators, Mechanical/supply & distribution
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour F-FDG PET/CT functional parameters.
Autorzy :: Bae MR; Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Roh JL; Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Songnam, Gyeonggi-do, 13496, Republic of Korea. .
Kim JS; Departments of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi SH; Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Nam SY; Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SY; Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Pokaż więcej
Źródło :: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3341-3348. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Lymphatic Metastasis/*diagnosis
Squamous Cell Carcinoma of Head and Neck/*diagnosis
Uterine Cervical Neoplasms/*diagnosis
Adult ; Aged ; Disease-Free Survival ; Female ; Fluorodeoxyglucose F18/administration & dosage ; Humans ; Lymphatic Metastasis/diagnostic imaging ; Lymphatic Metastasis/pathology ; Middle Aged ; Multimodal Imaging ; Neoplasm Metastasis ; Neoplasm Staging ; Positron-Emission Tomography ; Squamous Cell Carcinoma of Head and Neck/diagnostic imaging ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/secondary ; Tumor Burden ; Uterine Cervical Neoplasms/diagnostic imaging ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/secondary
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Remnant gastric cancer: a neglected group with high potential for immunotherapy.
Autorzy :: Ramos MFKP; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil. .
Pereira MA; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
de Castria TB; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
Ribeiro RRE; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
Cardili L; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
de Mello ES; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
Zilberstein B; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
Ribeiro-Júnior U; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.
Cecconello I; Instituto do Cancer, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av Dr Arnaldo 251, Sao Paulo, SP, 01249000, Brazil.; Pokaż więcej
Źródło :: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3373-3383. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Immunotherapy/*methods
Stomach Neoplasms/*immunology
Stomach Neoplasms/*therapy
Adult ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/immunology ; Biomarkers, Tumor/genetics ; Female ; Gastrectomy ; Humans ; Kaplan-Meier Estimate ; Lymph Node Excision/methods ; Male ; Microsatellite Instability ; Middle Aged ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/immunology ; Receptor, ErbB-2/immunology ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Autorzy :: Saadeh FS; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Morsi RZ; Department of Neurology, University of Chicago, Chicago, Illinois, United States of America.
El-Kurdi A; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Nemer G; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Mahfouz R; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Charafeddine M; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Khoury J; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Najjar MW; Division of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Khoueiry P; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Assi HI; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 25; Vol. 15 (11), pp. e0242793. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Prognosis*
Exome/*genetics
Glioblastoma/*genetics
Neoplasm Proteins/*genetics
Codon, Nonsense/genetics ; Disease-Free Survival ; Female ; Glioblastoma/epidemiology ; Glioblastoma/pathology ; Humans ; Lebanon/epidemiology ; Male ; Middle Aged ; Mutation, Missense/genetics ; Whole Exome Sequencing
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Prediction of COVID-19 Patients at High Risk of Progression to Severe Disease.
Autorzy :: Dai Z; Department of Invasive Technology, Yancheng Clinical Medical College of Nanjing Medical University, Yancheng, China.
Zeng D; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Cui D; Department of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang D; Department of Infectious Disease, The Second People's Hospital of Yancheng City, Yancheng, China.
Feng Y; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Shi Y; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zhao L; Department of Gynecology and Obstetrics, Tongji Medical College, Wuhan Central Hospital, Huazhong University of Science and Technology, Wuhan, China.
Xu J; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Guo W; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yang Y; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zhao X; Department of Respiration, The Fifth People's Hospital of Wuxi, Wuxi, China.
Li D; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zheng Y; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wang A; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wu M; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Song S; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Lu H; Department of Infectious Disease and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.; Pokaż więcej
Źródło :: Frontiers in public health [Front Public Health] 2020 Nov 24; Vol. 8, pp. 574915. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Disease Progression*
Prognosis*
Severity of Illness Index*
COVID-19/*epidemiology
COVID-19/*physiopathology
Risk Assessment/*methods
Risk Assessment/*statistics & numerical data
Adult ; Age Factors ; Aged ; Aged, 80 and over ; China/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; ROC Curve ; Retrospective Studies ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Autorzy :: Zhang Z; Guangxi Medical University.
Liu C; Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Liang T; Guangxi Medical University.
Yu C; Guangxi Medical University.
Qin Z; Guangxi Medical University.
Zhou X; Guangxi Medical University.
Xue J; Guangxi Medical University.
Zeng H; Guangxi Medical University.
Lu Z; Guangxi Medical University.
Xu G; Guangxi Medical University.
Wang Z; Guangxi Medical University.
Chen J; Guangxi Medical University.
Jiang J; Guangxi Medical University.
Zhan X; Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Nov 13; Vol. 99 (46), pp. e23251.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Biomarkers, Tumor/*analysis
Osteosarcoma/*diagnosis
Biomarkers, Tumor/genetics ; Child ; Early Detection of Cancer/methods ; Early Detection of Cancer/standards ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic/genetics ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Immunotherapy/methods ; Kaplan-Meier Estimate ; Mass Screening/methods ; Mass Screening/standards ; Osteosarcoma/genetics ; Pediatrics/methods ; Pediatrics/trends ; Prospective Studies ; Survival Analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Autorzy :: Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: .
Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
Paré L; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
Pascual T; SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
Chic N; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
González-Farré B; SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.
Frassoldati A; Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S Anna University Hospital, Ferrara, Italy.
Sanfeliu E; SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.
Cejalvo JM; Department of Medical Oncology, Hospital Clínico Universitario of Valencia, Valencia, Spain.
Muñoz M; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Bisagni G; Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy.
Brasó-Maristany F; SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Urso L; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
Vidal M; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Brandes AA; Medical Oncology, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna.
Adamo B; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Musolino A; Department of Medicine and Surgery, and the Medical Oncology and Breast Unit, University Hospital of Parma, Piacenza, Italy.
Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
Conte B; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Oliveira M; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Saura C; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron University Hospital; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Pernas S; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Institut Català d'Oncologia Hospitalet, Hospitalet de Llobregat, Spain.
Alarcón J; SOLTI Breast Cancer Research Group, Barcelona, Spain; Hospital Universitario Son Espases, Carretera de Valldemossa, Palma de Mallorca, Spain.
Llombart-Cussac A; Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.
Cortés J; Department of Medical Oncology, Vall d'Hebron University Hospital; Vall d'Hebron Institute of Oncology, Barcelona, Spain; IOB Institute of Oncology, Quiron Group, Barcelona, Spain.
Manso L; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
López R; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Complejo Universitario de Santiago de Compostela-CIBERONC, Santiago de Compostela, Spain.
Ciruelos E; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Schettini F; SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, University of Naples Federico II, Naples, Italy.
Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Carey LA; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Perou CM; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Piacentini F; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
D'Amico R; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy.
Tagliafico E; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy.
Parker JS; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy; Department of Medical Oncology UO Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1455-1464.
Typ publikacji :: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Prognosis*
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*genetics
Trastuzumab/*administration & dosage
Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Bridged-Ring Compounds/administration & dosage ; Bridged-Ring Compounds/adverse effects ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Proportional Hazards Models ; Taxoids/administration & dosage ; Taxoids/adverse effects ; Trastuzumab/adverse effects ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study.
Autorzy :: Witteler J; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Kjaer TW; Neurological Department, Zealand University Hospital, Roskilde, Denmark.
Tvilsted S; Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark.
Schild SE; Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
Rades D; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany .; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2020 Nov; Vol. 40 (11), pp. 6513-6515.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Brain Neoplasms/*radiotherapy
Glioma/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Aged ; Brain Neoplasms/pathology ; Brain Neoplasms/surgery ; Disease-Free Survival ; Female ; Glioma/pathology ; Glioma/surgery ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Re-Irradiation/adverse effects ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
Autorzy :: Ahmed A; German Cancer Research Center (DKFZ), Department of Translational Immunotherapy, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.
Halama N; German Cancer Research Center (DKFZ), Department of Translational Immunotherapy, Heidelberg, Germany .; National Center for Tumor Diseases, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2020 Nov; Vol. 40 (11), pp. 6367-6373.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Colorectal Neoplasms/*pathology
Liver Neoplasms/*pathology
Tertiary Lymphoid Structures/*pathology
Adult ; Aged ; Aged, 80 and over ; CD3 Complex/immunology ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/immunology ; Female ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Progression-Free Survival ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Tertiary Lymphoid Structures/diagnostic imaging ; Tertiary Lymphoid Structures/immunology ; Tumor Microenvironment/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
Autorzy :: Liu S; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
Lin Z; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
Zheng Z; Department of Pathology, Quanzhou First Hospital of Fujian Medical University, Quanzhou, China.
Rao W; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
Lin Y; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
Chen H; Department of Radiation Oncology, Anxi County Hospital, Quanzhou, China.
Xie Q; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.
Chen Y; Department of Thoracic Surgery, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China.
Hu Z; Department of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Pokaż więcej
Źródło :: Cancer science [Cancer Sci] 2020 Oct; Vol. 111 (10), pp. 3881-3892. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Esophageal Squamous Cell Carcinoma/*genetics
Homeodomain Proteins/*genetics
MicroRNAs/*genetics
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Disease-Free Survival ; Esophageal Squamous Cell Carcinoma/pathology ; Exosomes/genetics ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness/genetics ; Neoplasm Staging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 in Gallbladder Carcinoma.
Autorzy :: Kim SJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SW; Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Oh CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Hong M; Department of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
DO SI; Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea.
Kim YW; Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Kim HS; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea .
Na K; Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea .; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2020 Oct; Vol. 40 (10), pp. 5777-5785.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
RNA-Binding Proteins*/genetics
Carcinoma/*genetics
Gallbladder Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Carcinoma/pathology ; Female ; Gallbladder Neoplasms/pathology ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Male ; Middle Aged ; RNA, Messenger/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: A novel predictive tool for prognosis in elderly patients with urinary tract infection: Modified PRACTICE.
Autorzy :: Ryu S; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Oh SK; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea. Electronic address: .
Cho SU; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
You Y; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Park JS; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Min JH; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Jeong W; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Cho YC; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Ahn HJ; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.
Kang C; Department of Emergency Medicine, Chungnam National University Hospital, Republic of Korea.; Pokaż więcej
Źródło :: The American journal of emergency medicine [Am J Emerg Med] 2020 Oct; Vol. 38 (10), pp. 2002-2006. Date of Electronic Publication: 2020 Jun 27.
Typ publikacji :: Journal Article
MeSH Terms :: Prognosis*
Geriatrics/*instrumentation
Serum Albumin/*analysis
Urinary Tract Infections/*complications
Aged ; Aged, 80 and over ; Area Under Curve ; Biomarkers/analysis ; Biomarkers/blood ; Chi-Square Distribution ; Emergency Service, Hospital/organization & administration ; Emergency Service, Hospital/statistics & numerical data ; Female ; Geriatrics/methods ; Geriatrics/standards ; Humans ; Male ; ROC Curve ; Retrospective Studies ; Severity of Illness Index ; Statistics, Nonparametric ; Survival Analysis ; Urinary Tract Infections/blood ; Urinary Tract Infections/diagnosis
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""prognosis"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język